Mitochondrial dysfunction in myeloid cells: a central deficit in autoimmune diseases

Area of Science:

• Immunology
• Cellular Metabolism
• Mitochondrial Biology

Background:

• Autoimmune diseases result from genetic and environmental factors disrupting immune tolerance.
• Myeloid cell immunometabolism, especially mitochondrial dysfunction, is increasingly implicated in autoimmunity.
• Mitochondria are crucial for immune cell energy and fate, and their impairment contributes to chronic inflammation.

Purpose of the Study:

• To explore the role of chronic metabolic stress and mitochondrial dysfunction in myeloid cells during autoimmunity.
• To propose a model where metabolic stress reprograms myeloid cells, creating a cycle of cell death and immune activation.
• To highlight the potential of targeting mitochondrial function for autoimmune disease therapies.

Main Methods:

• Review of recent studies on myeloid cell immunometabolism and autoimmunity.
• Conceptual framework development linking metabolic stress, mitochondrial dysfunction, and immune dysregulation.
• Analysis of proposed mechanisms of myeloid cell maladaptation in autoimmune conditions.

Main Results:

• Chronic metabolic stress can reprogram myeloid cells, leading to impaired immune cell differentiation and function.
• Mitochondrial dysfunction fuels a cycle of cell death and aberrant immune activation.
• Myeloid cell maladaptation may result from sustained metabolic insults.

Conclusions:

• Viewing autoimmune diseases through a metabolic lens provides novel insights into pathogenesis.
• Therapeutic strategies targeting mitochondrial function hold promise for restoring immune balance in autoimmunity.
• Understanding myeloid cell immunometabolism is key to developing effective treatments for autoimmune disorders.